A recent study by Sachs and colleagues showed that combined treatment with PEGylated-insulin and GLP-1-estrogen conjugate reverses STZ-induced diabetes, mainly by inducing the proliferation and redifferentiation of dedifferentiated β-cells (Sachs et al., 2020). Here, GCG is linked to diabetes mellitus.